NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Rafina Innovations Inc (PINK: VICA)
VICA Technical Analysis
1
As on N/A VICA STOCK Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS. |
VICASTOCK Price
Open | N/A | Change | Price | % |
High | N/A | 1 Day | N/A | N/A |
Low | N/A | 1 Week | N/A | N/A |
Close | N/A | 1 Month | N/A | N/A |
Volume | N/A | 1 Year | N/A | N/A |
52 Week High N/A | 52 Week Low N/A |
PINK USA Most Active Stocks
TXGE | 2699.59 | -0.54% |
APLD | 8.98 | 6.78% |
CYBL | 0.01 | % |
CLNV | 0.02 | 0.00% |
WRFX | 0.01 | % |
AMXVF | 1.05 | 10.53% |
VDRM | 0.01 | % |
HTZZ | 24.68 | 1.52% |
CRGE | 0.02 | -33.33% |
GVSI | 0.01 | % |
PINK USA Top Gainers Stocks
PINK USA Top Losers Stocks
VICA Daily Charts |
VICA Intraday Charts |
Whats New @ Bazaartrend |
VICA Free Analysis |
|
VICA Important Levels Intraday
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE |
VICA Forecast January 2025
4th UP Forecast | |
3rd UP Forecast | |
2nd UP Forecast | |
1st UP Forecast | |
1st DOWN Forecast | |
2nd DOWN Forecast | |
3rd DOWN Forecast | |
4th DOWN Forecast |
VICA Weekly Forecast
4th UP Forecast | |
3rd UP Forecast | |
2nd UP Forecast | |
1st UP Forecast | |
1st DOWN Forecast | |
2nd DOWN Forecast | |
3rd DOWN Forecast | |
4th DOWN Forecast |
VICA Forecast2025
4th UP Forecast | |
3rd UP Forecast | |
2nd UP Forecast | |
1st UP Forecast | |
1st DOWN Forecast | |
2nd DOWN Forecast | |
3rd DOWN Forecast | |
4th DOWN Forecast |
Rafina Innovations Inc ( PINK USA Symbol : VICA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VICA Other Details
Segment | EQ | |
Market Capital | 1497386.00 | |
Sector | Healthcare | |
Industry | Medical Devices | |
Offical website | > echo $website ; ?> |
VICA Address
VICA Latest News
VICA Business Profile
Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies. It operates through two segments, Clinics and Technology. The company also operates prosthetics and orthotics, and diabetic foot total rehabilitation clinics in Southern Europe, the Middle East, and North Africa. In addition, it is involved in the research, development, and commercialization of medical devices, methods, and products in the fields of prosthetics, orthotics, rehabilitation, bioengineering, mobility, diabetes, diabetic foot, tissue mechanics, ultrasonics, medical signal processing and analysis, medical technology, orthopedics, and robotic surgery; and licensing of its proprietary technologies. The company was formerly known as HCi Viocare and changed its name to Rafina Innovations Inc. in July 2018. Rafina Innovations Inc. was founded in 2007 and is based in Glasgow, the United Kingdom. Address: Kintyre House, Glasgow, United Kingdom, G51 1HJ
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service